Search Results for: Idera Pharmaceuticals Announces Launch of
Articles
March 6, 2018
Idera Pharmaceuticals Announces Launch of Global Phase 3 Trial March 6, 2018
Idera Pharmaceuticals, Inc. recently announced the start of a Phase 3 global, multi-center, open-label clinical trial to evaluate the efficacy...
January 4, 2021
EyePoint Pharmaceuticals Announces $15.7-Million Equity Investment January 4, 2021
EyePoint Pharmaceuticals, Inc. recently announced Ocumension Therapeutics has made a $15.7-million equity investment in EyePoint. Under the terms of the...
October 7, 2012
Mayne Pharma Announces Major Acquisition October 7, 2012
Mayne Pharma Group Limited recently announce it has entered into a binding agreement to acquire Metrics, Inc. Consideration for the...
November 30, 2021
APTAMER TECHNOLOGY - From Postal Codes to GPS: Building Better Drug Conjugates With Aptamers November 30, 2021
David Bunka, PhD, and Emily Robinson, PhD, focus on a new breed of affinity binders that can be used as an alternative to antibody therapeutics and has the potential to reshape the industry, delivering new medicines with improved safety and efficacy profiles and reduced healthcare costs.
August 27, 2018
DRUG DEVELOPMENT - Cell & Gene Therapies Calling for Innovation in Drug Development August 27, 2018
Lev Gerlovin and Pascale Diesel, PharmD, believe there is significant evidence to indicate that we are entering a golden age of gene and cell therapy development, and while industry works to advance these programs, the debate over new approaches in both structuring and financing clinical research is likely to continue.
February 11, 2013
2/13/2013 February 11, 2013
Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential...
October 7, 2012
10/10/2012 October 7, 2012
Cleveland BioLabs & Incuron Announce Orphan Drug Status Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company...
July 30, 2012
8/1/2012 July 30, 2012
BD Launches Thin-Wall Needle Technology BD Medical recently announced the launch of the BD Hyflow needle, a unique 27-gauge thin-wall...
March 29, 2012
4/3/2012 March 29, 2012
Aptar Pharma's Device Delivers INSYS Therapeutics' Drug Aptar Pharma recently announced INSYS Therapeutics' SUBSYS, which uses an Aptar Pharma Sublingual...
February 16, 2012
2/21/2012 February 16, 2012
Catalent Pharma Solutions & NewMarket Sign Development Agreement Catalent Pharma Solutions and NewMarket Pharmaceuticals LLC recently announced they have entered...
October 27, 2011
11/01/2011 October 27, 2011
Activartis Develops Cancer Vaccine in Phase II, Seeks Partner Activartis GmbH (formerly Trimed Biotech GmbH) recently announced it is developing...
May 5, 2011
5/10/2011 May 5, 2011
QRxPharma Completes Patient Enrolment of Phase III Comparative Safety Study QRxPharma Limited recently announced it has completed patient enrolment for...
March 27, 2011
3/29/2011 March 27, 2011
Champions Biotechnology Announces Technology Collaboration With CephalonChampions Biotechnology, Inc. recently announced the signing of a technology collaboration agreement with Cephalon,...
